南京中医药大学学报
南京中醫藥大學學報
남경중의약대학학보
Journal of Nanjing University of Traditional Chinese Medicine
2015年
6期
560-563
,共4页
朱磊%沈洪%顾培青%刘丽%朱长乐%司海鹏
硃磊%瀋洪%顧培青%劉麗%硃長樂%司海鵬
주뢰%침홍%고배청%류려%주장악%사해붕
溃疡性结肠炎%健脾补肾方%骨髓间充质干细胞%增殖%炎症
潰瘍性結腸炎%健脾補腎方%骨髓間充質榦細胞%增殖%炎癥
궤양성결장염%건비보신방%골수간충질간세포%증식%염증
ulcerative colitis%Jianpi-Bushen Fang%mesenchymal stem cells%proliferation%inflammation
目的:观察健脾补肾方促进骨髓间充质干细胞(Bone mesenchymal stem cells,BMSCs)增殖、分化治疗溃疡性结肠炎(Ulcerative colitis,UC)模型大鼠的可能作用机制。方法 SD 大鼠随机分为空白组、模型组、BMSCs 组、干预 BMSCs 组和联合组。采用 TNBS 法建立大鼠 UC 模型,干预 BMSCs 和联合组大鼠分别尾静脉注射体外中药干预的 BMSCs(0.78 mg/L,1×106),联合组再予健脾补肾方(浓度13.6 g/kg)灌胃10 d,BMSCs 组大鼠尾静脉注射1 mL BMSCs(1×106),空白组、模型组大鼠尾静脉分别注射1 mL 生理盐水。干预第10天每组各处死5只大鼠,留取标本,Western blot 法检测大鼠结肠组织肠干细胞标记物 Lgr5和 Ephrin-B3的蛋白表达水平,检测 E-cadherin 的蛋白表达水平,采用 ELISA 法检测各组大鼠结肠组织 IL-6、IL-17和 TGF-β水平。结果各移植治疗组较模型组,Lgr5和 Ephrin-B3蛋白水平升高(P <0.05),联合组 Lgr5和 Ephrin-B3蛋白表达较 BMSCs 组,差异有统计学意义(P <0.05);各治疗组 E-cadherin 蛋白表达较模型组均升高,其中联合组和干预BMSCs 组较模型组,差异有统计学意义(P <0.05),联合组较 BMSCs 组,差异有统计学意义(P <0.05);联合组和干预 BMSCs组 IL-6、IL-17水平明显降低(P <0.05),TGF-β水平升高(P <0.05),且联合组在改善 IL-6、TGF-β水平方面较单纯 BMSCs 治疗有统计学意义(P <0.05)。结论健脾补肾方能够促进静脉移植的 BMSCs 向肠干细胞增殖分化,并调节免疫功能、修复肠黏膜,这可能是其治疗 UC 的可能机制之一。
目的:觀察健脾補腎方促進骨髓間充質榦細胞(Bone mesenchymal stem cells,BMSCs)增殖、分化治療潰瘍性結腸炎(Ulcerative colitis,UC)模型大鼠的可能作用機製。方法 SD 大鼠隨機分為空白組、模型組、BMSCs 組、榦預 BMSCs 組和聯閤組。採用 TNBS 法建立大鼠 UC 模型,榦預 BMSCs 和聯閤組大鼠分彆尾靜脈註射體外中藥榦預的 BMSCs(0.78 mg/L,1×106),聯閤組再予健脾補腎方(濃度13.6 g/kg)灌胃10 d,BMSCs 組大鼠尾靜脈註射1 mL BMSCs(1×106),空白組、模型組大鼠尾靜脈分彆註射1 mL 生理鹽水。榦預第10天每組各處死5隻大鼠,留取標本,Western blot 法檢測大鼠結腸組織腸榦細胞標記物 Lgr5和 Ephrin-B3的蛋白錶達水平,檢測 E-cadherin 的蛋白錶達水平,採用 ELISA 法檢測各組大鼠結腸組織 IL-6、IL-17和 TGF-β水平。結果各移植治療組較模型組,Lgr5和 Ephrin-B3蛋白水平升高(P <0.05),聯閤組 Lgr5和 Ephrin-B3蛋白錶達較 BMSCs 組,差異有統計學意義(P <0.05);各治療組 E-cadherin 蛋白錶達較模型組均升高,其中聯閤組和榦預BMSCs 組較模型組,差異有統計學意義(P <0.05),聯閤組較 BMSCs 組,差異有統計學意義(P <0.05);聯閤組和榦預 BMSCs組 IL-6、IL-17水平明顯降低(P <0.05),TGF-β水平升高(P <0.05),且聯閤組在改善 IL-6、TGF-β水平方麵較單純 BMSCs 治療有統計學意義(P <0.05)。結論健脾補腎方能夠促進靜脈移植的 BMSCs 嚮腸榦細胞增殖分化,併調節免疫功能、脩複腸黏膜,這可能是其治療 UC 的可能機製之一。
목적:관찰건비보신방촉진골수간충질간세포(Bone mesenchymal stem cells,BMSCs)증식、분화치료궤양성결장염(Ulcerative colitis,UC)모형대서적가능작용궤제。방법 SD 대서수궤분위공백조、모형조、BMSCs 조、간예 BMSCs 조화연합조。채용 TNBS 법건립대서 UC 모형,간예 BMSCs 화연합조대서분별미정맥주사체외중약간예적 BMSCs(0.78 mg/L,1×106),연합조재여건비보신방(농도13.6 g/kg)관위10 d,BMSCs 조대서미정맥주사1 mL BMSCs(1×106),공백조、모형조대서미정맥분별주사1 mL 생리염수。간예제10천매조각처사5지대서,류취표본,Western blot 법검측대서결장조직장간세포표기물 Lgr5화 Ephrin-B3적단백표체수평,검측 E-cadherin 적단백표체수평,채용 ELISA 법검측각조대서결장조직 IL-6、IL-17화 TGF-β수평。결과각이식치료조교모형조,Lgr5화 Ephrin-B3단백수평승고(P <0.05),연합조 Lgr5화 Ephrin-B3단백표체교 BMSCs 조,차이유통계학의의(P <0.05);각치료조 E-cadherin 단백표체교모형조균승고,기중연합조화간예BMSCs 조교모형조,차이유통계학의의(P <0.05),연합조교 BMSCs 조,차이유통계학의의(P <0.05);연합조화간예 BMSCs조 IL-6、IL-17수평명현강저(P <0.05),TGF-β수평승고(P <0.05),차연합조재개선 IL-6、TGF-β수평방면교단순 BMSCs 치료유통계학의의(P <0.05)。결론건비보신방능구촉진정맥이식적 BMSCs 향장간세포증식분화,병조절면역공능、수복장점막,저가능시기치료 UC 적가능궤제지일。
OBJECTIVE To explore the mechanism of ulcerative colitis(UC)treatment by Jianpi-Bushen Fang through pro-moting the differentiation of BMSCs in model rats.METHODS The rats were divided into 5 groups:normal group,model group,BMSCs group,BMSCs intervene group and combine group.BMSCs intervene group and combine group were injected with decoction intervened BMSCs through tail veins in vitro (1×106/mL),the combine group were also given the decoction in oral for 10 d.BMSCs group were injected with BMSCs through tail veins(1×10 6/mL).The normal and model groups were in-jected with 1 mL of normal saline through tail veins.5 rats were killed on 10th day after the intervention,respectively,for specimen.The expression of Lgr5,Ephrin-B3 and E-cadherin were detected with Western blot,and the levels of IL-6,IL-17 and TGF-βwith ELISA assay.RESULTS The expression of Lgr5 and Ephrin-B3 in treatment groups increased(P <0.05), compared with the model group.E-cadherin in treatment groups increased compared with the model group,and the combine group and BMSCs intervene group increased significantly(P <0.05).The levels of IL-6 and IL-17 in combine group and BM-SCs group significantly decreased(P <0.05),while TGF-βincreased(P <0.05).The difference between the combine group and BMSCs group was significant(P <0.05) in Lgr5,Ephrin-B3,E-cadherin,IL-6 and TGF-βexpression.CONCLUSION Jianpi-Bushen Fang can promote the venously transplanted BMSCs proliferation and differentiation into intestinal stem cell, regulate immune function and repair intestinal mucosa,which may be one possible mechanism for UC treatment.